BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siljee S, Buchanan O, Brasch HD, Bockett N, Patel J, Paterson E, Purdie GL, Davis PF, Itinteang T, Tan ST. Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System. Cells 2021;10:243. [PMID: 33513805 DOI: 10.3390/cells10020243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Kilmister EJ, Koh SP, Weth FR, Gray C, Tan ST. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment. Biomedicines 2022;10:2988. [DOI: 10.3390/biomedicines10112988] [Reference Citation Analysis]
2 Hosseini-dastgerdi H, Kharazmi F, Pourshanazari A, Nematbakhsh M, Kershaw DB. Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors. International Journal of Nephrology 2022;2022:1-11. [DOI: 10.1155/2022/8731357] [Reference Citation Analysis]
3 Kapoor-Narula U, Lenka N. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. Cytokine 2022;157:155968. [PMID: 35872504 DOI: 10.1016/j.cyto.2022.155968] [Reference Citation Analysis]
4 Kilmister EJ, Tan ST. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System. Front Surg 2022;9:868187. [DOI: 10.3389/fsurg.2022.868187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 O'Rawe M, Wickremesekera AC, Pandey R, Young D, Sim D, FitzJohn T, Burgess C, Kaye AH, Tan ST. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48-54. [PMID: 34929651 DOI: 10.1016/j.jocn.2021.11.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Parvanova I, Borziak K, Guarino J, Finkelstein J. A Platform for Integrating and Sharing Cancer Stem Cell Data. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021. [DOI: 10.1109/embc46164.2021.9630083] [Reference Citation Analysis]
7 Humphries F, Chang-McDonald B, Patel J, Bockett N, Paterson E, Davis PF, Tan ST. Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma. Front Oncol 2021;11:690460. [PMID: 34621666 DOI: 10.3389/fonc.2021.690460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Munro MJ, Peng L, Wickremesekera SK, Tan ST. Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors. PLoS One 2021;16:e0256280. [PMID: 34428252 DOI: 10.1371/journal.pone.0256280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 O'Rawe M, Kilmister EJ, Mantamadiotis T, Kaye AH, Tan ST, Wickremesekera AC. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma. Cancers (Basel) 2021;13:4004. [PMID: 34439159 DOI: 10.3390/cancers13164004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Kilmister EJ, Tan ST. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche. J Histochem Cytochem 2021;:221554211026295. [PMID: 34165363 DOI: 10.1369/00221554211026295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Siljee S, Milne B, Brasch HD, Bockett N, Patel J, Davis PF, Kennedy-Smith A, Itinteang T, Tan ST. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma. Biomolecules 2021;11:537. [PMID: 33916968 DOI: 10.3390/biom11040537] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]